Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Rabbit Monoclonal Antibodies Developed for Immunohistochemistry Applications

By LabMedica International staff writers
Posted on 02 Mar 2010
A new range of rabbit monoclonal and polyclonal antibodies has been developed for immunohistochemistry (IHC) applications. More...
A rabbit custom antibody service is also available.

Antibodies produced by rabbits are reported often to provide superior antigen recognition, greater specificity, and better consistency than those offered by mice. Rabbit antibodies can recognize specific antigens and epitopes that are not immunogenic in mice or rats. These antibodies can sometimes also offer higher working titers and may therefore help to lower laboratory costs. By using rabbit monoclonal antibodies (RMAbs), researchers can benefit from these unique qualities especially in the area of immunohistochemistry. Use of RMAbs technology provides critical information to researchers regarding the distribution and localization of biomarkers, and differentially expressed proteins in different parts of a biologic tissue.

AMSBIO (Abingdon, UK) offers a range of over 3,500 antibodies for immunohistochemistry including rabbit monoclonal, polyclonal, and mouse monoclonal antibodies (MAbs). Included in this range are antibodies that have been characterized to work on FFPE sections, renowned for their robust, highly sensitive, and specific characteristics. Many of these antibodies have been CE marked. The AMSBIO SP1 Estrogen Receptor antibody is now recommended as the gold standard by leading breast cancer experts and distributed worldwide.

AMS Biotechnology (AMSBIO) is a leading international provider of products and custom services for life sciences research. The AMSBIO range includes over 23,000 polyclonal and monoclonal antibodies, peptides, recombinant proteins, extracellular matrix, molecular detection reagents, tissue DNA, RNA, protein, and microarray products. Key research areas include apoptosis, cell invasion and migration, cell signaling, DNA damage, electrophoresis, glycobiology, posttranslational modification, and stem cell biology.

Related Links:

AMSBIO



Gold Member
Aspiration System
VACUSAFE
Online QC Software
Acusera 24•7
POC Immunoassay Analyzer
Procise DX
New
Automated Coagulation Analyzer
Hemolumi H6
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers use a novel immobilized liposome-bound gel beads method to measure CEC levels and their association with cardiovascular risks (Photo courtesy of Institute of Science Tokyo)

Simple Blood-Based Cholesterol Efflux Assay Identifies High-Risk Coronary Plaque Features

Unstable coronary plaques are difficult to identify before they trigger acute cardiovascular events. Standard high-density lipoprotein (HDL) measurements do not always capture how well HDL particles function... Read more

Pathology

view channel
Image: Overview of the uncertainty-aware lensfree computational pathology platform for automated HER2 assessment. A compact lensfree holographic imaging system captures diffraction patterns from immunohistochemically stained breast tissue samples, which are computationally reconstructed and analyzed using deep neural networks with Bayesian uncertainty quantification. (Photo courtesy of Ozcan Lab, UCLA)

Uncertainty-Aware AI Platform Supports Automated HER2 Assessment in Breast Cancer

Accurate assessment of human epidermal growth factor receptor 2 (HER2) is critical for breast cancer diagnosis and treatment selection, yet scoring variability and infrastructure requirements can complicate... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.